Cornelia Hardt

Title: Cornelia Hardt: Innovator in Antitumoral Arenavirus Research

Introduction

Cornelia Hardt is a prominent inventor based in Bochum, Germany. She has made significant contributions to the field of medical research, particularly in the development of antitumoral therapies. Her innovative work focuses on the creation of arenavirus mutants with enhanced therapeutic properties.

Latest Patents

Cornelia Hardt holds a patent for a "Method for producing an antitumoral arenavirus as well as arenavirus mutants." This invention relates to a mutant of an arenavirus that exhibits improved antitumoral properties. The patent also encompasses a method for generating such arenavirus mutants, along with related pharmaceutical compositions, medical uses, methods of treatment, and isolated proteins and nucleic acids. She has 1 patent to her name.

Career Highlights

Cornelia is associated with Abalos Therapeutics GmbH, where she applies her expertise in virology and oncology. Her work is pivotal in advancing therapeutic options for cancer treatment, showcasing her commitment to improving patient outcomes through innovative research.

Collaborations

Cornelia collaborates with notable colleagues, including Karl Lang and Michael Bergerhausen. Their combined efforts contribute to the advancement of research in the field of antitumoral therapies.

Conclusion

Cornelia Hardt's innovative work in the development of antitumoral arenavirus mutants positions her as a key figure in medical research. Her contributions are vital for the future of cancer treatment and demonstrate the importance of innovation in healthcare.